Statistics and Data Management Core

统计和数据管理核心

基本信息

项目摘要

Project Summary – Statistics and Data Management Core – Core C Scientific rigor and reproducibility have become a priority in preclinical research in recent years. Important features of these concepts include sound study design, statistical analysis, and the validation and sharing of study data and statistical programming code. The Statistics and Data Management Core's primary objectives are to provide targeted research support and education in study design and data analysis, and to provide an integrated web-based research database system to enhance the scientific rigor and transparency of Center research. The Core provides statistical research support in rigorous experimental design, sample size estimation, and effective data analysis methods to minimize bias and to ensure robust results for all UC Davis CounterACT Center investigations. Core C will also continue, in close partnership with the Research Education Core, to deliver education and training to investigators, research staff and graduate students on study design and statistical methods tailored to CounterACT scientific objectives. The Center's REDCap research database system facilitates effective and efficient data capture, utilization and sharing within and outside the UC Davis CounterACT Center. This database is critical to the reproducibility of scientific findings as it promotes timely and transparent reporting of study data. The Statistics and Data Management Core consists of three faculty statisticians with considerable experience in experimental design and analysis of preclinical and clinical data— including high-throughput data such as imaging and metabolomics— and database systems. All three also have considerable (10+ years) experience in collaborative multidisciplinary research. To distribute efforts across Core C's faculty statisticians and analytical staff and to encourage collaboration across projects and cores, each experiment is assigned a primary faculty statistician and analyst to support the design, data collection, data analysis, and reporting of results. Brief weekly meetings of Core C personnel provide an efficient forum to discuss statistical and database management challenges and to share ideas and methods for addressing them. By providing targeted statistical expertise, analytical and database support, and training, the Statistics and Data Management Core promotes the scientific rigor and reproducibility of research findings by the UC Davis CounterACT Center of Excellence.
项目总结-统计和数据管理核心-核心C

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel Joseph Tancredi其他文献

Daniel Joseph Tancredi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel Joseph Tancredi', 18)}}的其他基金

Core C: Statistics Core
核心 C:统计核心
  • 批准号:
    10684079
  • 财政年份:
    2022
  • 资助金额:
    $ 26.79万
  • 项目类别:
Bioanalytical and Statistics Core
生物分析和统计核心
  • 批准号:
    10179379
  • 财政年份:
    1997
  • 资助金额:
    $ 26.79万
  • 项目类别:
Bioanalytical and Statistics Core
生物分析和统计核心
  • 批准号:
    9917779
  • 财政年份:
  • 资助金额:
    $ 26.79万
  • 项目类别:

相似海外基金

Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10004277
  • 财政年份:
    2020
  • 资助金额:
    $ 26.79万
  • 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10475298
  • 财政年份:
    2020
  • 资助金额:
    $ 26.79万
  • 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10693904
  • 财政年份:
    2020
  • 资助金额:
    $ 26.79万
  • 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
  • 批准号:
    10013749
  • 财政年份:
    2020
  • 资助金额:
    $ 26.79万
  • 项目类别:
Study on how anticonvulsants affect car driving
抗惊厥药如何影响汽车驾驶的研究
  • 批准号:
    20K17977
  • 财政年份:
    2020
  • 资助金额:
    $ 26.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
  • 批准号:
    10266034
  • 财政年份:
    2020
  • 资助金额:
    $ 26.79万
  • 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
  • 批准号:
    10475109
  • 财政年份:
    2020
  • 资助金额:
    $ 26.79万
  • 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10248384
  • 财政年份:
    2020
  • 资助金额:
    $ 26.79万
  • 项目类别:
Prevention of neuropathic pain by antidepressants and anticonvulsants: in vivo patch-clamp analysis
抗抑郁药和抗惊厥药预防神经性疼痛:体内膜片钳分析
  • 批准号:
    24592355
  • 财政年份:
    2012
  • 资助金额:
    $ 26.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
  • 批准号:
    8492175
  • 财政年份:
    2009
  • 资助金额:
    $ 26.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了